People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

A new and increasingly widely used diabetes medication may have additional health benefits for older adults, according to new ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

Discover how modern diabetes medications offer cardiovascular benefits, transforming diabetes care and improving outcomes worldwide.

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

Groundbreaking research reveals how common diabetes medications might offer unprecedented protection against heart attacks ...

A new study finds SGLT2 inhibitors like Jardiance and GLP-1 drugs like Ozempic provide different benefits depending on the ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

A majority with overweight/obesity discontinue within a year, but the rate is higher among those without type 2 diabetes.